|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
A valiant captivia stent graft was intended to be implanted during the endovascular treatment of a 88mm thoracoabdominal aneurysm.The patient's aorta was noted as double s-shaped with small access vessels at the iliacs.It was reported that during the index procedure the patient's iliacs were too small to place the valiant captivia so a conduit was placed for access.Once the wires were placed a sentrant sheath was placed into the conduit and the vamf4036c150tu was implanted into the patient.Power injector run was taken to confirm placement before deployment and it was noticed that contrast was stagnant in the aorta.The patient deteriorated and cpr was administered and the graft was removed.The patient expired.Per the physician the cause of death was anatomy related due to unforeseen anatomical complications including the small access requiring a conduit, double s-shaped aorta, and the patients' body habitus was small.The patient had complex and diseased anatomy, and in an attempt to fix the thoracic aneurysm, the an infrarenal aneurysm ruptured.No additional sequelae were reported and the patients is expired.
|